BioNTech SE

NASDAQ: BNTX · Real-Time Price · USD
110.88
0.11 (0.10%)
At close: Aug 22, 2025, 3:59 PM
110.16
-0.65%
After-hours: Aug 22, 2025, 04:47 PM EDT

BioNTech SE Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-402.7M -445.4M 259.5M 195.46M -811.89M -316.95M 663.2M 227.4M -412.2M 707.7M 3.17B 2.44B 2.32B 5.02B 4.71B 4.67B 4.02B 1.64B
Depreciation & Amortization
51M 42.8M 165.4M 43.81M 50.15M 38.53M 78.8M 41.3M 31.9M 31.4M 29M 33.5M 33.2M 27.6M 26M 19.8M 16.4M 13M
Stock-Based Compensation
32.1M 22.1M 23.5M n/a 13.4M 16.3M 14.2M 15.5M 13.1M 8.6M 26.9M 61.4M 14.8M 9.4M 18.1M 23.1M 22M 17.3M
Other Working Capital
n/a n/a n/a n/a n/a n/a 49.69M n/a 24.5M n/a -50.48M n/a n/a n/a n/a n/a n/a n/a
Other Non-Cash Items
-70.9M 16.3M -51.7M -178.15M -2.26B -411.31M -158.4M -150.7M -156.6M -1.44B -925.6M -642.6M -1.05B -1.5B -4.6M 86.2M 154.4M -23.5M
Deferred Income Tax
n/a n/a n/a -50.7M n/a n/a 1.06B 38.3M -781M -37.32M n/a n/a n/a n/a -3.49B -196.7M -71.9M -32.6M
Change in Working Capital
537M -416.5M -860M -649.31M 2.38B 223.81M -803.8M 639.4M 5.69B 47.7M -1.47B 2.88B 2.6B 497.2M -1.46B -3.1B -4.24B -1.93B
Operating Cash Flow
146.5M -780.7M -463.3M -638.9M 1.64B -319.17M 850.9M 811.2M 4.39B -677.4M 829.2M 4.78B 3.92B 4.05B -199.5M 1.5B -100.3M -311.3M
Capital Expenditures
-30.2M -618.1M -91.1M -81.62M -141.83M -137.71M -190.2M -151.2M -309.3M -54.8M -144.5M -82.6M -75.4M -60.8M -53.4M -41.3M -30.1M -29.2M
Cash Acquisitions
n/a -78.5M 737.25K 292.57K 201.69K n/a 4.26M -336.9M n/a n/a 186.81K 434.54K 17.29M n/a -20.8M 199.51K 304.45K 922.35K
Purchase of Investments
-1.67B -2.51B -2.07B -2.9B -2.45B -4.92B -3.72B -744.1M -1.98B -680.6M -16.7M -1.1M -3M -27M -410.88M -367M n/a n/a
Sales Maturities Of Investments
1.64B 4.45B 2.77B 2.84B 2.35B 2.74B 1.18B 97.2M n/a n/a -7.59M -11.74M -9.49M 375.2M n/a n/a n/a n/a
Other Investing Acitivies
-2.6M -568.7M -24.54M 3.96M -152.8M -2.25B 1.11B -97.2M -2.22B -690.2M 7.61M 11.71M -7.8M 331.5M -392.7M 200K 300K 900K
Investing Cash Flow
-64.4M 1.25B 606.7M -142.1M -232.32M -2.32B -2.7B -1.23B -2.29B -735.4M -161M -83.3M -78.4M 287.4M -466.9M -41.1M -29.8M -28.3M
Debt Repayment
-13.3M -13.8M -8.71K -7.9M n/a -7.8M -12.1M n/a -9.4M -9.3M -9M 1.02M -10.3M -30.2M -48.9M -5.3M -8M -4.5M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a -800K -301.7M -154M -282M -55.7M -643.8M -286.9M n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -9.8M -15.15M -484.3M n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -7.29M n/a -22.9M -45.91K -12.1M -9.3M n/a n/a n/a -10.62M n/a n/a n/a n/a n/a n/a
Financial Cash Flow
-13.3M -13.8M -7.3M -7.9M -23.06M -7.85M -12.9M -311M -163.4M -291.3M -64.7M -653.4M -781.5M 80.3M -48.9M -5.3M 152.9M -4.5M
Net Cash Flow
84.6M 423M 137.3M -752.1M 1.4B -2.69B -1.83B -670.8M 2.02B -1.73B 451.4M 4.09B 3.17B 4.47B -700M 1.48B 22.6M -318.7M
Free Cash Flow
116.3M -1.4B -554.4M -699.41M 1.5B -456.87M 660.7M 660M 4.08B -732.2M 684.7M 4.7B 3.84B 3.99B -252.9M 1.46B -130.4M -340.5M